Novo Nordisk A/S – Share repurchase programme

Novo Nordisk A/S announced a share repurchase program on July 13, 2026, in accordance with MAR and the Safe Harbour Rules. This program is part of a larger initiative to repurchase up to DKK 15 billion worth of shares over a 12-month period starting February 4, 2026. Specifically, under the program initiated on May 6, 2026, Novo Nordisk will repurchase B shares up to a value of DKK 11,200,000,010.45 between May 6, 2026, and February 1, 2027. Between July 6 and July 10, 2026, the company repurchased 975,000 B shares for a total transaction value of DKK 313,791,553. As of July 10, 2026, Novo Nordisk holds 41,169,480 B shares as treasury shares, representing 0.9% of the total share capital. Cumulatively, since February 4, 2026, the company has repurchased 23,984,179 B shares for DKK 6,534,545,458.